Fibrous dysplasia (FD) is a common benign bone disorder of an unclear etiology. It is known that FD can appear without an increased FDG uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). However, there are also several reports that FD showed increased FDG uptake and this mimicked malignant bone involvement on FDG-PET. Herein we describe a case of bi...

increased metabolic activity in muscle secondary to excessive muscle activity during the uptake phase and shortly before fdg injection is a known phenomenon. we present fdg pet/ct findings in a young male, known case of carcinoma maxilla his scan showed diffuse increased metabolic activity in multiple skeletal muscle groups. there was history of unaccustomed, strenuous sports activity of skiing...

A 76-year-old man with symptomatic bone metastases from castrationresistant prostate cancer underwent Radium-223-dichloride (Ra-223) therapy. Before Ra-223 therapy, he had normal peripheral blood cell counts. Ra-223 therapy relieved his shoulder and low back pain. The elevation of the serum prostate-specific antigen (PSA), doubling every month during Ra-223 therapy, suggested a PSA flare or rel...

Medical efforts and financial expenditures devoted to initial breast cancer staging represent a heavy burden on health care resources. Staging the disease accurately is considered to be important before surgery, in order to spare unnecessary treatment to patients with metastatic disease [1]. The role of 2-[fluorine-18]fluoro-2-deoxy-D-glucose–positron emission tomography (FDG-PET) in the stagin...

UNLABELLED PET with (18)F-FDG is used for detection and staging of thoracic cancer; however, more specific PET radiopharmaceuticals would be welcome. (11)C-labeled choline (CHOL) is a new radiopharmaceutical potentially useful for tumor imaging, since it is incorporated into cell membranes as phosphatidylcholine. The aim of this study was to investigate whether (11)C-CHOL PET has advantages ove...

  Introduction: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GIST has been shown to over-express c-KIT (CD117), the receptor tyrosine kinase. Imatinib (STI571 or Glivec) is a new type of tyrosine kinase inhibitor that selectively inhibits various tyrosine kinases and has been successfully used to trea...

UNLABELLED The transition from stable to progressive disease is unpredictable in patients with biochemical evidence of medullary thyroid carcinoma (MTC). Calcitonin and carcinoembryonic antigen (CEA) doubling times are currently the most reliable markers for progression, but for accurate determination, serial measurements, which need time, are required. We compared (18)F-FDG PET and (18)F-dihyd...

For locally advanced cervical cancer, the current literature supports the use of (18)F-FDG PET for assessing treatment response 3 mo after the completion of concurrent chemoradiation. (18)F-FDG PET can provide reliable long-term prognostic information for these patients and, in the future, may be used to guide additional therapy. Investigational areas include the use of (18)F-FDG PET for monito...

With great interest, we read the article by Inal A. et al on the comparison FDG-PET/CT and Bone scan in bone metastasis of NSCLC (April issue 2014, Contemporary Oncology) [1]. We would like to ask the authors two questions. First, we usually take a maximum standard uptake value into consideration in evaluating metastasis in FDG-PET/CT [2]. How about the value in this study population? How much ...